Pfizer Quarterly Corporate Performance — Fourth Quarter 2009
Audio Webcast — Conference
call for Analysts and Investors
Wednesday, February 3, 2010
10:00 AM E.D.T.
Read press release issued December 23, 2009 (PDF)
Performance Report — Fourth Quarter 2009
Download and Print Presentation (543 KB) PDF
28th Annual J.P. Morgan Healthcare Conference
Audio Webcast —
Tuesday, January 12, 2010
8:30 AM P.S.T
Read press release issued January 5, 2010 (PDF)
Download and Print Presentation (1.96 MB) PDF
Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
Audio Webcast —
Wednesday, January 6, 2010
8:30 AM E.D.T
Read press release issued January 4, 2010 (PDF)
More Investor Presentations 
2009 Corporate Responsibility Report
Part of being a responsible company is operating with transparency. That's why
Pfizer has created a Corporate Responsibility Report to detail our priorities: discovering and developing new medicines, improving access to medicines and partnering to find health system solutions.
View the Interactive 2009 Corporate Responsibility Report 
Wyeth Transaction
Important Information for Investors
Access key merger documents 
Effective October 15, 2009 Pfizer Inc. acquired Wyeth in a cash and stock merger. Pursuant to the terms of the merger, Wyeth holders will receive 0.985 of a share of Pfizer Inc. common stock and $33.00, without interest for every 1 share of Wyeth common stock they own as of the effective date. Holders who own their shares in "street name" or with a broker are urged to contact their broker accordingly for further instructions. Registered holders who hold either certificates, book entry shares and/or participate in the Wyeth BuyDIRECT Stock Purchase and Sale Plan dividend reinvest program will receive information in the mail shortly regarding how to exchange their shares.
Access key merger documents 
Working Mother 100 Best Companies
Pfizer has been named among the 2009 Working Mother 100 Best Companies.
View the press release 
Visit workingmother.com 
Best Places to Work for LGBT Equality
For the sixth consecutive year, Pfizer earns the highest score in the Human Rights Campaign Foundation's LGBT Ranking.
View the press release 